AUTHOR=Gevaert Andreas B. , Mueller Stephan , Winzer Ephraim B. , Duvinage André , Van de Heyning Caroline M. , Pieske-Kraigher Elisabeth , Beckers Paul J. , Edelmann Frank , Wisløff Ulrik , Pieske Burkert , Adams Volker , Halle Martin , Van Craenenbroeck Emeline M. , for the OptimEx-Clin Study Group TITLE=Iron Deficiency Impacts Diastolic Function, Aerobic Exercise Capacity, and Patient Phenotyping in Heart Failure With Preserved Ejection Fraction: A Subanalysis of the OptimEx-Clin Study JOURNAL=Frontiers in Physiology VOLUME=Volume 12 - 2021 YEAR=2022 URL=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2021.757268 DOI=10.3389/fphys.2021.757268 ISSN=1664-042X ABSTRACT=Aims - Iron deficiency (ID) is linked to reduced aerobic exercise capacity and poor prognosis in patients with heart failure (HF) with reduced ejection fraction, however, data for HF with preserved ejection fraction (HFpEF) is scarce. We assessed the relationship between iron status and diastolic dysfunction as well as aerobic exercise capacity in HFpEF, and the contribution of iron status to patient phenotyping. Methods and results - Among 180 patients with HFpEF (67% women; median age, 71 years) recruited for the Optimizing Exercise Training in Prevention and Treatment of HFpEF (OptimEx-Clin) trial, baseline iron status including iron, ferritin and transferrin saturation was analyzed (n=169) in addition to exercise capacity (peakV̇O2) and diastolic function (E/e’). ID was present in 60% of patients, and was more common in women. In multivariable linear regression models, we found that diastolic function and peakV̇O2 were independently related to iron parameters, however these relations were only present in HFpEF patients with ID (E/e’ and iron: ß -0.19 (95% confidence interval -0.32, -0.07), p=0.003; E/e’ and transferrin saturation: ß -0.16 (-0.28,-0.04), p=0.011; peakV̇O2 and iron: ß 3.76 (1.08,6.44), p=0.007; peakV̇O2 and transferrin saturation: ß 3.58 (0.99, 6.16), p=0.007). Applying machine learning, patients were clustered into three phenogroups. One phenogroup was predominantly characterized by female sex, few HFpEF risk factors but high prevalence of ID (86%, p<0.001 vs. other phenogroups). When excluding iron deficiency from the phenotyping analysis, results were negatively influenced. Conclusions - Iron parameters are independently associated with impaired diastolic function and low aerobic capacity in patients with HFpEF and ID. Patient phenotyping in HFpEF is influenced by including ID. Registration - Optimizing Exercise Training in Prevention and Treatment of Diastolic Heart Failure (OptimEx-Clin), ClinicalTrials.gov NCT02078947